White-Cell β-Galactosidase Activity
- 5 March 1970
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 282 (10), 571
- https://doi.org/10.1056/nejm197003052821018
Abstract
To the Editor: The differential diagnosis between patients with generalized gangliosidosis and several types of genetic mucopolysaccharidoses can be a problem. In both groups of disorders the lysosomal enzyme β-galactosidase has been shown to be deficient in liver, spleen, kidney, brain and skin.1 2 3 The diagnosis of GM1 gangliosidosis is based on clinical phenotype coupled with a normal concentration of derinatan and heparin sulfate in the urine and the absence of β-galactosidase in the liver. Recently Sloan4 reported a case with deficiency of this enzyme in cultured fibroblasts. Since fibroblasts and leukocytes have similar embryologic origins, it seemed a . . .Keywords
This publication has 8 references indexed in Scilit:
- G M1 ‐gangliosidosis without chondrodystrophy or visceromegalyNeurology, 1970
- β-Galactosidase in Tissue Culture Derived from Human Skin and Bone Marrow: Enzyme defect in GM1 GangliosidosisPediatric Research, 1969
- Beta-Galactosidase Deficiency in the Hurler SyndromeNew England Journal of Medicine, 1969
- Hurler's Syndrome: Deficiency of a Specific Beta Galactosidase IsoenzymeScience, 1969
- Generalized gangliosidosisThe Journal of Pediatrics, 1969
- The Abnormalities of Lysosomal Enzymes in MucopolysaccharidosesEuropean Journal of Biochemistry, 1968
- Acid hydrolases in skin and plasma in gargoylism. Deficiency of β-galactosidase in skinClinica Chimica Acta; International Journal of Clinical Chemistry, 1968
- Isolation of β-galactosidase and β-glucosidase from brainBiochimica et Biophysica Acta (BBA) - Enzymology and Biological Oxidation, 1966